Bafna Pharmaceuticals Limited — Investor Relations & Filings
Bafna Pharmaceuticals Limited specializes in the development, manufacture, and marketing of a diverse range of pharmaceutical formulations. The company operates manufacturing facilities certified by WHO-GMP standards, ensuring high-quality production of finished dosage forms including tablets, capsules, syrups, and suspensions. Its therapeutic portfolio spans multiple categories such as anti-infectives, analgesics, cardiovascular, gastrointestinal, and vitamins. The organization serves both domestic and international markets, with a significant presence in emerging regions across Africa, Southeast Asia, and the CIS. In addition to its proprietary product line, the company provides comprehensive contract manufacturing and formulation development services, leveraging its technical expertise and regulatory compliance to meet global healthcare requirements.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Financial Results Updates | 2021-02-15 | English | |
| Outcome of Board Meeting | 2021-02-12 | English | |
| Financial Result Updates | 2021-02-12 | English | |
| Board Meeting — Financial Results/Other business matters | 2021-02-02 | English | |
| Related Party Transactions | 2021-01-20 | English | |
| Reply to Clarification- Financial results | 2020-12-16 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
5 filings
| |||||
| 43249046 | Financial Results Updates | 2021-02-15 | English | ||
| 43290996 | Outcome of Board Meeting | 2021-02-12 | English | ||
| 43291081 | Financial Result Updates | 2021-02-12 | English | ||
| 44025293 | Board Meeting — Financial Results/Other business matters | 2021-02-02 | English | ||
| 43249915 | Related Party Transactions | 2021-01-20 | English | ||
|
2020
10 filings
| |||||
| 43253818 | Reply to Clarification- Financial results | 2020-12-16 | English | ||
| 43271005 | Resignation | 2020-11-12 | English | ||
| 43271018 | Appointment | 2020-11-12 | English | ||
| 43271012 | Appointment | 2020-11-12 | English | ||
| 43275282 | Financial Result Updates | 2020-11-12 | English | ||
| 43275937 | Outcome of Board Meeting | 2020-11-12 | English | ||
| 44025288 | Board Meeting — Financial Results/Other business matters | 2020-11-02 | English | ||
| 43278576 | Reply to Clarification- Financial results | 2020-09-24 | English | ||
| 43286031 | Price movement | 2020-09-23 | English | ||
| 43321123 | Appointment | 2020-09-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Bafna Pharmaceuticals Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62471/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62471 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62471 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62471 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62471}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Bafna Pharmaceuticals Limited (id: 62471)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.